Sort
23,748 grants matching “melanoma”
Molecular Determinants of Androgen Receptor Function
$254,994Elizabeth M. Wilson · Univ Of North Carolina Chapel Hill · U54 · FY2011 · HD
Overcoming Resistance to RAF Inhibition in BRAF-Mutant Colorectal Cancer
$254,973Levi Alexander Garraway · Dana-Farber Cancer Inst · P50 · FY2017 · CA
Advancing RAS and RASopathy Therapies
$254,957Marielle Yohe · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Neoantigen immunotherapy in brain tumors using anti-CD27 to deplete regulatory T cells selectively
$254,856John H Sampson · Duke University · P50 · FY2023 · CA
Isolation Chemistry of Tropical Plants and Biological Evaluation
$254,852Alan Douglas Kinghorn · Ohio State University · P01 · FY2015 · CA
Project 1: Genotoxic & Cell Signaling Pathways of As in Mammalian Cells
$254,839Tom K Hei · Columbia University Health Sciences · P42 · FY2009 · ES
IMMUNIZATION AGAINST MELANOMA DIFFERENTIATION ANTIGENS
$254,800Sloan-Kettering Institute For Cancer Res · R01 · FY2003 · CA
Targeting ROS enzymes in immunosuppressive myeloid cells to enhance immunotherapy
$254,788Tracy W Liu · West Virginia University · P20 · FY2025 · GM
Neural Predictors and RAS Modulation of Radiation-induced Cognitive Impairment
$254,713Judy K Brunso-Bechtold · Wake Forest University Health Sciences · R01 · FY2006 · CA
WUSM CANCER AND LEUKEMIA GROUP B
$254,695Washington University · U10 · FY2001 · CA
Role of HOS in Cell Transformation and Apoptosis
$254,682Serge Y Fuchs · University Of Pennsylvania · R01 · FY2012 · CA
Role of HOS in Cell Transformation and Apoptosis
$254,682Serge Y Fuchs · University Of Pennsylvania · R01 · FY2015 · CA
ADHESION JUNCTION REGULATION IN NORMAL AND DISEASED SKIN
$254,625University Of North Carolina Chapel Hill · R01 · FY2004 · AI
ADHESION JUNCTION REGULATION IN NORMAL AND DISEASED SKIN
$254,625University Of North Carolina Chapel Hill · R01 · FY2005 · AI
ADHESION JUNCTION REGULATION IN NORMAL AND DISEASED SKIN
$254,625University Of North Carolina Chapel Hill · R01 · FY2003 · AI
ADHESION JUNCTION REGULATION IN NORMAL AND DISEASED SKIN
$254,625University Of North Carolina Chapel Hill · R01 · FY2001 · AI
WP760 for Malignant Melanoma Therapy
$254,615Houston Pharmaceuticals, Inc. · R41 · FY2004 · CA
Exploiting the distinct genomics and signaling of colorectal cancers to effectively target ERK
$254,557Rona Yaeger · Sloan-Kettering Inst Can Research · R01 · FY2023 · CA
Cornell- Common Fund Data Supplement Regulation of the Melanocyte Lineage by the AP2 Transcription Factor Family
$254,500Robert Aaron Cornell · University Of Iowa · R01 · FY2019 · AR
Endothelial cell injury by cytolytic lymphocytes
$254,500Virginia Commonwealth University · R01 · FY2003 · HL
ENGINEERING T CELLS FOR PANCREATIC CANCER
$254,484Helen E Heslop · Baylor College Of Medicine · P01 · FY2017 · CA
ENGINEERING T CELLS FOR PANCREATIC CANCER
$254,484Helen E Heslop · Baylor College Of Medicine · P01 · FY2015 · CA
ENGINEERING T CELLS FOR PANCREATIC CANCER
$254,482Helen E Heslop · Baylor College Of Medicine · P01 · FY2016 · CA
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
$254,475Linda Mac Pherson Bradley · Sanford Burnham Prebys Medical Discovery Institute · R21 · FY2017 · CA
PSGL-1, a New Player in the Immune Checkpoint Landscape
$254,475Linda Mac Pherson Bradley · Sanford Burnham Prebys Medical Discovery Institute · R21 · FY2017 · CA